Immune Reconstitution to Measles Virus of HIV Infected Children in Zambia

• Status: Completed
• Trial end date: 2012-02-01
• Target enrollment: 0
• Participant gender: All

Summary

This is an observational study of HIV-1 infected children starting antiretroviral therapy to measure the magnitude and quality of general immune reconstitution and pathogen-specific immune reconstitution to measles virus.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of North Carolina, Chapel Hill
• Collaborator: National Institute of Allergy and Infectious Diseases (NIAID)

Criteria

Inclusion Criteria:

• Boys and girls 9 months to 10 years of age residing in Lusaka, Zambia are eligible for enrolment.

• initiating ART

• history of measles vaccination confirmed by examination of the Immunization Card.